| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 51.2814 | 52 |
| GSM780708 | Untreated after 4 days (C2_1) | 46.5097 | 34 |
| GSM780709 | Untreated after 4 days (C3_1) | 48.3997 | 43 |
| GSM780719 | Untreated after 4 days (C1_2) | 46.8502 | 36 |
| GSM780720 | Untreated after 4 days (C2_2) | 52.8965 | 56 |
| GSM780721 | Untreated after 4 days (C3_2) | 50.1279 | 49 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 47.5576 | 39 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 40.3032 | 7 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 53.8534 | 58 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 51.9621 | 54 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 47.8612 | 41 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 48.2363 | 42 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 48.7882 | 44 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 47.9578 | 41 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 63.8087 | 67 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 42.9502 | 17 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.4031 | 43 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 48.2843 | 42 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 59.3521 | 64 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 43.9529 | 22 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 49.4438 | 47 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 45.264 | 28 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 56.2439 | 61 |